References
- US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health and Objectives for Improving Health (Volume 1). US Government Printing Office, Washington, DC, USA (2000).
- Goff DC Jr, Brass L, Braun LT et al. Essential features of a surveillance system to support the prevention and management of heart disease and stroke. A scientific statement from the American Heart Association Councils on epidemiology and prevention, stroke, and cardiovascular nursing and the interdisciplinary working groups on quality of care and outcomes research and atherosclerotic peripheral vascular disease. Circulation115(1), 127–155 (2006).
- Drazen JM, Morrissey S, Curfman GD. Rosiglitazone – continued uncertainty about safety. N. Engl. J. Med.357(1), 63–64 (2007).
- Curfman GD, Morrissey S, Jarcho JA, Drazen JM. Drug-eluting coronary stents – promise and uncertainty. N. Engl. J. Med.356(10), 1059–1060 (2007).
- Vogt TM, Elston-Lafata J, Tolsma D, Greene SM. The role of research in integrated healthcare systems: the HMO Research Network. Am. J. Manag. Care10, 643–648 (2004).
- Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am. J. Cardiol.100(4), 690–696 (2007).
Website
- American Heart Association Strategic Goals www.americanheart.org/presenter?identifier=4429